Zhenyu Zhu

机构：Kyoto University · ORCID：0000-0001-5344-3161

发表论文 46 篇 · 总被引 532 次 · h-index 15

代表论文

• Efficacy, safety, and prognostic factors of PD-1 inhibitors combined with lenvatinib and Gemox chemotherapy as first-line treatment in advanced intrahepatic cholangiocarcinoma: a multicenter real-world study (2023 · Cancer Immunology Immunotherapy · 被引 34)
• M1 macrophages impair tight junctions between endothelial cells after spinal cord injury (2022 · Brain Research Bulletin · 被引 31)
• Tocilizumab promotes repair of spinal cord injury by facilitating the restoration of tight junctions between vascular endothelial cells (2023 · Fluids and Barriers of the CNS · 被引 26)
• Chinese Expert Consensus on Immunotherapy for Hepatocellular Carcinoma (2021 Edition) (2022 · Liver Cancer · 被引 22)
• Chinese expert consensus on sequential surgery following conversion therapy based on combination of immune checkpoint inhibitors and antiangiogenic targeted drugs for advanced hepatocellular carcinoma (2024 edition) (2024 · BioScience Trends · 被引 21)
• Consensus of Chinese Experts on Neoadjuvant and Conversion Therapies for Hepatocellular Carcinoma: 2023 Update (2024 · Liver Cancer · 被引 19)